SANSONE, S.; AMIR, Y.; LEBWOHL, M. Safe use of Interleukin-17 Inhibitors for Psoriasis and Psoriatic Arthritis in Two Patients with a History of Lymphoproliferative Disease. SKIN The Journal of Cutaneous Medicine, v. 4, n. 3, p. 256-259, 8 May 2020.